Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $204.73M-15.4% | $185.74M-28.3% | $192.44M-30.5% | $219.83M-19.9% | $241.86M-11.8% | ||
| $144.76M-4.6% | $151.75M+0.6% | $151.9M+2.1% | $152.71M+2.7% | $151.67M-1.1% | ||
| $59.97M-33.5% | $33.99M-68.6% | $40.54M-68.3% | $67.12M-46.7% | $90.19M-25.3% | ||
| 29.3%-8.0pp | 18.3%-23.5pp | 21.1%-25.2pp | 30.5%-15.3pp | 37.3%-6.7pp | ||
| $16.4M-14.0% | $17.4M-9.5% | $18.18M-5.6% | $19.04M+0.7% | $19.08M+5.0% | ||
| $134.65M-16.1% | $145.12M-10.3% | $154.78M-2.7% | $158.47M-0.2% | $160.45M+4.5% | ||
| $20.71M+258,913% | $17.83M+1,561% | $7.39M+40.8% | -$4K-100% | -$8K-100% | ||
| —— | —— | $54.85M-64.4% | $209.08M— | $178.64M— | ||
| $267.86M-32.1% | $288.89M-31.4% | $274.34M— | $425.5M— | $394.69M— | ||
| -$168.26M+36.7% | -$215.27M+8.6% | -$194.17M+5.3% | -$318.76M-481% | -$265.92M-401% | ||
| -82.2%+27.8pp | -115.9%-25.0pp | -100.9%-26.8pp | -145%-125pp | -109.9%-90.6pp | ||
| $25.96M-40.5% | $26.99M-43.4% | $31.7M-38.8% | $38.49M-22.8% | $43.61M-2.9% | ||
| $10.08M-56.9% | $11.44M-58.3% | $15.09M-47.7% | $19.36M-33.7% | $23.42M-18.9% | ||
| -$4.67M-89.4% | -$4.15M-74.2% | -$4.11M-72.4% | -$3.97M-65.9% | -$2.47M-70.3% | ||
| -$188.81M+35.3% | -$234.97M+10.1% | -$218.04M-149% | -$345.03M-158% | -$291.76M-149% | ||
| -$4.53M-130% | -$4.22M-127% | -$4.23M-101% | -$3.82M-101% | -$1.97M-100% | ||
| -$104.56M+35.7% | -$130.77M+9.7% | -$121M+46.2% | -$192.52M-43.4% | -$162.71M-24.2% | ||
| -51.1%+16.2pp | -70.4%-14.5pp | -62.9%+18.4pp | -87.6%-38.7pp | -67.3%-19.5pp | ||
| -$0.71+37.7% | -$0.90+11.8% | -$0.84+48.8% | -$1.34-32.7% | -$1.14-15.2% | ||
| -$0.71+37.7% | -$0.90+11.8% | -$0.84+48.8% | -$1.34-32.7% | -$1.14-15.2% | ||
| 579.7M+3.8% | 576.7M+5.3% | 570.3M+5.3% | 567.1M+6.6% | 558.7M+5.8% | ||
| 579.7M+3.8% | 576.7M+5.3% | 570.3M+5.3% | 567.1M+6.6% | 558.7M+5.8% | ||
| —— | $68.71M-58.6% | $93.07M-25.3% | $117.43M+41.4% | $141.79M+241% | ||
| -$4.67M-89.4% | -$4.15M-74.2% | -$4.11M-72.4% | -$3.97M-65.9% | -$2.47M-70.3% | ||
| $204.73M-15.4% | $185.74M-28.3% | $192.44M-30.5% | $219.83M-19.9% | $241.86M-11.8% | ||
| -$168.26M+36.7% | -$215.27M+8.6% | -$194.17M+5.3% | -$318.76M-481% | -$265.92M-401% | ||
| -$118.1M+45.4% | -$163.76M+12.5% | -$142.74M+9.8% | -$268.57M-2,869% | -$216.47M-2,069% | ||
| -$118.1M+45.4% | -$163.76M+12.5% | -$142.74M+9.8% | -$268.57M-2,869% | -$216.47M-2,069% | ||
| -57.7%+31.8pp | -88.2%-15.9pp | -74.2%-17.0pp | -122.2%-119pp | -89.5%-85.9pp | ||
| -$168.26M+36.7% | -$215.27M+8.6% | -$194.17M+5.3% | -$318.76M-481% | -$265.92M-401% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $204.7M in revenue over the trailing twelve months, down 15.3% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $104.6M over the trailing twelve months, a -51.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 29.3% and operating margin is -82.2%, with a -51.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.71.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
